Cambridge Healthtech Institute’s 8th Annual

Gene Therapy Manufacturing

August 16-17, 2023


Cambridge Healthtech Institute’s Gene Therapy Manufacturing conference discusses the practical challenges facing the production, purification, and manufacturing of viral and non-vector-based gene therapies. Topics include: AAV and lentivirus upstream development, the removal and control of process-related impurities, purification, and manufacturing strategies for clinical and commmerical supply.


Coverage will include, but is not limited to:


  • AAV process development
  • Lentivirus process development
  • Cell line development
  • HTPD strategies to improve manufacturability
  • Upstream production and scaling-up – moving to suspension systems
  • Manufacturability
  • Process intensification and continuous processing
  • Recovery and purification
  • Commercial manufacturing strategies -- external vs. internal vs. shared capacity
  • Non-viral gene therapy technical development and manufacture
  • Formulation
  • Drug product and administering to patients


The deadline for priority consideration is February 3, 2023.


All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.


Opportunities for Participation:



For more details on the conference, please contact:

Daniel Barry

Senior Conference Director

Cambridge Healthtech Institute

Phone: (+44) 7837-651-303



For sponsorship information, please contact:

Companies A-M

Phillip Zakim-Yacouby

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-247-1815



Companies N-Z

Aimee Croke

Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-292-0777